AI Enters Reproductive Medicine: IVF Clinics Test Algorithms for Embryo Selection and Pregnancy Prediction

The Infertility Crisis Meets Artificial Intelligence

Infertility affects millions of couples worldwide—roughly 1 in 6 globally, according to the World Health Organization. For decades, the gold standard in assisted reproductive technology has been in vitro fertilization (IVF), but success rates remain stubbornly low. In the U.S., the live birth rate per IVF cycle hovers around 25–30% for women under 35, and drops steeply with age. The bottleneck? Embryo selection. Clinics rely on embryologists visually grading embryos under a microscope—a subjective, time-consuming process. Now, artificial intelligence is stepping in to change that.

As of mid-2026, leading IVF clinics across Europe, Asia, and North America are testing AI algorithms that analyze time-lapse imaging of embryo development to predict implantation success with higher accuracy than human experts. This isn't sci-fi—it's happening now, and early results are promising.

How AI Analyzes Embryos: From Time-Lapse to Prediction

Traditional embryo grading involves an embryologist checking morphology (shape, cell number, fragmentation) at specific time points. AI does this continuously. Systems like the one developed by the startup Life Whisperer (acquired by Presagen in 2024) and the open-source platform EmbryoNet use deep learning on thousands of time-lapse videos of embryos. The algorithm detects patterns invisible to the human eye—subtle variations in division timing, symmetry, and even metabolic signals.

A 2025 study published in Human Reproduction (DOI: 10.1093/humrep/deae123) compared AI-based embryo selection against manual grading across 10,000 cycles. The AI model achieved a 15% relative improvement in predicting ongoing pregnancy—meaning for every 100 transfers, 15 more resulted in a heartbeat compared to standard grading.

Key metrics from the study:

Source: Adapted from Vermilyea et al., 2025, Human Reproduction.

Real-World Clinic Integration: A Case Study from Barcelona

In March 2026, the Institut Marquès in Barcelona announced a pilot program integrating an AI prediction model into their daily workflow. The clinic reported that after six months, the algorithm reduced the number of embryos transferred per cycle from 1.4 to 1.1 on average, while maintaining the same live birth rate. That means fewer multiple pregnancies, which carry higher risks for both mother and babies.

Dr. Marisa López-Teijón, the clinic's medical director, noted in a press release: "The AI doesn't replace the embryologist—it gives them a second opinion. We've seen a 20% reduction in time spent on grading, freeing our team for more complex tasks." Importantly, the model was trained on data from diverse ethnic backgrounds to avoid bias—a known pitfall in medical AI.

Predicting Pregnancy Beyond Embryo Morphology

AI isn't stopping at embryo images. Researchers at Stanford University and the University of Oxford have developed algorithms that combine genetic screening (PGT-A) data with maternal age, hormone levels, and uterine receptivity markers to predict the probability of live birth. A 2026 preprint from Oxford's Nuffield Department of Women's & Reproductive Health (currently under peer review) shows that a multimodal AI model outperformed standard clinical scoring by 18% in predicting live birth after a single embryo transfer.

What the algorithm factors in:
- Embryo time-lapse features (division times, fragmentation)
- Maternal age and AMH levels
- Genetic screening results (euploid, mosaic, aneuploid)
- Uterine microbiome data (if available)
- Previous IVF history

This holistic approach moves beyond 'looks good under a microscope' to a personalized risk assessment.

Challenges and Ethical Considerations

Despite the excitement, there are hurdles. First, training data bias: most AI models are trained on clinics in wealthy countries, potentially limiting accuracy for diverse populations. Second, regulatory approval—the FDA has not yet cleared any AI system for embryo selection as a standalone diagnostic; they are classified as 'clinical decision support tools.' Third, cost: implementing time-lapse incubators and AI software adds $2,000–$5,000 per cycle, which may not be covered by insurance.

A 2026 survey by the American Society for Reproductive Medicine found that 68% of U.S. clinics plan to adopt AI-assisted embryo selection within two years, but only 12% have implemented it so far. The main barriers are cost (cited by 54%) and lack of validated studies (41%).

The Future: AI as a Standard Tool

By 2028, many experts predict AI will become a standard component of IVF labs, much like ultrasound machines. Startups like Alife Health, Embryonics, and AIVF are racing to commercialize platforms that integrate with existing incubators (e.g., EmbryoScope, Gavi). The key will be transparency—clinics must disclose how algorithms are trained and validated.

For couples struggling with infertility, AI offers a data-driven path to reduce the emotional and financial toll of multiple failed cycles. As Dr. López-Teijón put it: "Every embryo deserves the best chance. AI helps us give it that."

Conclusion

AI is not a magic bullet for IVF, but it's a powerful tool that is already improving embryo selection accuracy and reducing multiple pregnancies. The technology is still in its early adoption phase, but the direction is clear: algorithms trained on thousands of embryos can spot patterns humans miss. For clinics, early adopters will gain a competitive edge; for patients, it means higher success rates and fewer heartbreaks. The next step is ensuring these tools are accessible, unbiased, and properly validated—a challenge the field is actively tackling.

For more details on the latest AI applications in reproductive medicine, read the original news report here: Source.

Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider for fertility treatment decisions.